Business Wire

Survey Says: Project Leaders Need More PMTQ

Share

Project Management Institute (PMI) today released its Pulse of the Profession® report which reveals that organizations wasted almost 12 percent of their investment in project spend last year due to poor performance—a number that’s barely budged over the past five years. As a solution, PMI is calling on project leaders worldwide to evaluate and bolster their Project Management Technology Quotient or PMTQ. PMI developed the tenets of PMTQ by drawing on insights from innovator companies that put a high priority on digital skills acquisition and knowledge coupled with a commitment to a strong project management culture.

PMTQ adds a layer of project management to the concept of technology quotient (TQ), which is defined as a person’s ability to adapt, manage and integrate content advances in technology for a project or organization.

"In jobs of the future, project teams will be more and more reliant on technology as either an enabler or sometimes as a team member," said Murat Bicak, Senior Vice President, Strategy of PMI. "Having a strong PMTQ, and being technologically fluent, will be essential for anyone charged with making strategy reality."

Data from the 2019 Pulse of the Profession, PMI’s annual global survey of project management professionals, were used to identify PMTQ Innovators – organizations that prioritize the development of digital skills for project management – vs. the Laggards.

KEY COMPONENTS OF PMTQ

  • Always-on curiosity: Project managers with a high PMTQ are always looking for what’s next and trying out new project delivery approaches, ideas, perspectives and technology. Pulse data reveals that PMTQ Innovators demonstrate a strong ability to shift their way of getting work done. In fact, 60 percent of organizations indicate using hybrid project management practices, compared to 29 percent of PMTQ Laggards.
  • All-inclusive leadership: Those with a high PMTQ not only effectively manage people, but also technology — as well as people who are managing technology. An impressive 78 percent of PMTQ Innovators prioritize developing project management business skills, including management of people, versus only 5 percent of PMTQ Laggards, according to Pulse data.
  • A futureproof talent pool: PMTQ Innovators recruit and retain project talent with the skills needed for the digital workforce. They identify employees who can keep up with the trends and adapt their abilities accordingly. According to Pulse data, 82 percent of PMTQ Innovators (vs. 9 percent of PMTQ Laggards) prioritize developing project management technical skills and 81 percent provide ongoing project manager training (vs. 34 percent of PMTQ Laggards).

Gaining and maintaining a superior PMTQ requires support from all levels of an organization. While business leaders often express a desire to gain more and more workers with the know-how to utilize technology, there is still a disconnect on how they are willing to achieve it. In fact, Accenture found that while 60 percent of business leaders had increased their AI investments in 2017, only 3 percent said they would invest significantly in training and reskilling programs through 2020.i Organization leaders must recognize the importance of building digital fluency across their organization, so project managers can best deliver on the tasks asked of them.

When business leaders take note and support project managers on their PMTQ quest, our Pulse of the Profession data shows PMTQ Innovator organizations take the lead on project outcomes. Their projects are more likely to meet their original goals and be delivered on time and within budget, while reducing scope creep and outright failure.

This not only means PMTQ Innovators save money and improve stakeholder satisfaction rates, but when projects do fail, the portion of the budget lost is less than the PMTQ Laggards (8.5 percent versus 16.3 percent).

Read more about the PMTQ in the latest Pulse of the Profession Survey, The Future of Work: Leading the Way With PMTQ, at www.PMI.org/Pulse.

About the PMI Pulse of the Profession® Survey

The Pulse of the Profession Survey was conducted online in November to December 2018. The report highlights feedback and insights from 3,133 project management professionals, 441 Project Management Office (PMO) directors, and 368 executive leaders from a range of industries, including information technology, financial services, manufacturing, government, energy, healthcare, construction, and telecom around the globe.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Founded in 1969, PMI delivers value for more than three million professionals working in nearly every country in the world through global advocacy, collaboration, education and research. We advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute.

i Reworking the Revolution, Accenture (2018)

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Ortega
Public Relations Specialist
Project Management Institute
14 Campus Blvd.
Newtown Square, PA 19073
Phone: +1 610 356 4600 X7030
E-mail: mary.ortega@pmi.org
Website: www.pmi.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye